Bokf Na Lowers Stake in Humana Inc. (NYSE:HUM)

Bokf Na lessened its position in shares of Humana Inc. (NYSE:HUM) by 54.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,942 shares of the insurance provider’s stock after selling 5,826 shares during the period. Bokf Na’s holdings in Humana were worth $1,737,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Lazard Asset Management LLC grew its position in Humana by 8.2% during the first quarter. Lazard Asset Management LLC now owns 406,993 shares of the insurance provider’s stock valued at $141,110,000 after acquiring an additional 30,778 shares during the period. Canada Pension Plan Investment Board lifted its stake in shares of Humana by 28.5% during the first quarter. Canada Pension Plan Investment Board now owns 527,225 shares of the insurance provider’s stock worth $182,799,000 after purchasing an additional 116,925 shares in the last quarter. Capital International Inc. CA lifted its stake in shares of Humana by 24.4% during the first quarter. Capital International Inc. CA now owns 12,809 shares of the insurance provider’s stock worth $4,441,000 after purchasing an additional 2,512 shares in the last quarter. Advisors Asset Management Inc. lifted its stake in shares of Humana by 4.5% during the first quarter. Advisors Asset Management Inc. now owns 5,370 shares of the insurance provider’s stock worth $1,862,000 after purchasing an additional 230 shares in the last quarter. Finally, Delap Wealth Advisory LLC acquired a new position in shares of Humana in the first quarter worth about $450,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on HUM. Truist Financial boosted their price target on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research note on Monday, July 15th. Morgan Stanley began coverage on Humana in a research note on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target on the stock. Jefferies Financial Group cut their price target on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Royal Bank of Canada cut their price target on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research note on Thursday, April 25th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $360.00 price target on shares of Humana in a research note on Tuesday, July 23rd. Fourteen equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus target price of $402.60.

Humana Stock Performance

Shares of NYSE:HUM traded up $6.23 during trading on Friday, hitting $392.63. 1,003,973 shares of the company traded hands, compared to its average volume of 1,301,923. Humana Inc. has a one year low of $298.61 and a one year high of $530.54. The stock has a market capitalization of $47.31 billion, a price-to-earnings ratio of 24.45, a PEG ratio of 2.27 and a beta of 0.51. The business’s fifty day moving average is $365.66 and its 200-day moving average is $347.02. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same period in the prior year, the company posted $9.38 EPS. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year. As a group, equities analysts predict that Humana Inc. will post 16.27 earnings per share for the current fiscal year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.